Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Flávia de Sousa Gehrke, Renata Kelly Kuniyoshi, Beatriz Ca Alves, Felipe Melo Cruz, Daniel de Iracema Gomes Cubero, Luke J. Peppone, Bruna Antenussi Munhoz, Auro Del Giglio, Fernando L.A. Fonseca
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 4, Iss 1, Pp n/a-n/a (2015)
Clinical and Translational Medicine, Vol 4, Iss 1, Pp n/a-n/a (2015)
BackgroundFatigue is common in cancer patients receiving adjuvant chemotherapy. To further understand the mechanism of fatigue and search for potential biomarkers, we conducted this prospective study. Methods We enrolled breast cancer (BC) patients b
Publikováno v:
Clinical and Translational Medicine
Background\ud Immunotherapy of patients suffering from the human epidermal growth factor receptor 2 overexpressing (HER-2+) breast cancers with the anti-HER-2 antibodies results in increase of the patients’ overall survival. However, no prophylacti
Autor:
Isaac D. Gukas, William J. M. Hrushesky, Michael W. Retsky, Rick A. Rogers, Romano Demicheli, Michael Baum, Patrice Forget, Jayant S. Vaidya, Katharine Pachmann, Marc De Kock
Publikováno v:
Clinical and Translational Medicine, Vol. 1, p. 17 [1-11] (2012)
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 1, Iss 1, Pp n/a-n/a (2012)
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 1, Iss 1, Pp n/a-n/a (2012)
Background A great deal of the public's money has been spent on cancer research but demonstrable benefits to patients have not been proportionate. We are a group of scientists and physicians who several decades ago were confronted with bimodal relaps